Progressive Supranuclear Palsy
Neurology·MeSH: Supranuclear Palsy, Progressive
Prevalence
5.0 / 100K
3 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Progressive Supranuclear Palsy?
BioSniper tracks 3 drugs in development for Progressive Supranuclear Palsy across 2 companies.
How many clinical trials target Progressive Supranuclear Palsy?
There are 2 clinical trials targeting Progressive Supranuclear Palsy tracked by BioSniper.
What is the prevalence of Progressive Supranuclear Palsy?
The estimated prevalence of Progressive Supranuclear Palsy is approximately 5.0 per 100,000 population.
Deep-dive into Progressive Supranuclear Palsy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis